Concepedia

Author

Simon Daenen

University of Groningen

Also Known As

Dutch Hematologie-Oncologie Vereniging Volwassenen Nederland (HOVON), S DAENEN, S Daenen, S M Daenen, S M G J Daenen, S. Daenen, S. M. G. J. Daenen, S.M.G.J Daenen, S.M.G.J. Daenen, Simon Daenen

111

Publications

3.6K

Citations

32

H-Index

68

Concepts

All Affiliations

University of GroningenUniversity Medical Center GroningenAmsterdam UMC Location University of AmsterdamRadboud University NijmegenErasmus MC
SD

About

Simon Daenen is an author at University of Groningen specializing in medicine, hematology, and health sciences.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

21

24

1.1K

2

Health Sciences

9

9

377

3

Engineering

1

1

51

4

Public Health

1

1

10

5

Blood Transplantation

1

1

78

Simon Daenen

×

45

Publications

3.1K

Citations

30

H-Index

YearCitations

Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?

Jan J. Cornelissen, Wim L.J. van Putten, Leo F. Verdonck,

Blood

2007

470

Effect of Priming with Granulocyte Colony-Stimulating Factor on the Outcome of Chemotherapy for Acute Myeloid Leukemia

Bob Löwenberg, Wim van Putten, Matthias Theobald,

New England Journal of Medicine

2003

384

Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia‐associated invasive fungal infections

Alexander C. A. P. Leenders, Simon Daenen, Rob L. H. Jansen,

British Journal of Haematology

1998

318

Value of different modalities of granulocyte-macrophage colony-stimulating factor applied during or after induction therapy of acute myeloid leukemia.

Bob Löwenberg, M. Boogaerts, Simon Daenen,

Journal of Clinical Oncology

1997

128

Prevalence and predictive factors of sleep apnoea syndrome in type 2 diabetic patients

J Laaban, Simon Daenen, Damien Léger,

Diabetes & Metabolism

2009

108

Retinoic acid as antileukemic therapy in a patient with acute promyelocytic leukemia and Aspergillus pneumonia

Simon Daenen, Edo Vellenga, OA van Dobbenburgh,

Blood

1986

108

Feasibility of Withholding Antibiotics in Selected Febrile Neutropenic Cancer Patients

Claudi Oude Nijhuis, Willem A. Kamps, Simon Daenen,

Journal of Clinical Oncology

2005

89

Cloretazine (VNP40101M), a Novel Sulfonylhydrazine Alkylating Agent, in Patients Age 60 Years or Older With Previously Untreated Acute Myeloid Leukemia

Francis G. Giles, David A. Rizzieri, Judith E. Karp,

Journal of Clinical Oncology

2006

84

Intensified chemotherapy inspired by a pediatric regimen combined with allogeneic transplantation in adult patients with acute lymphoblastic leukemia up to the age of 40

Anita W. Rijneveld, Bronno van der Holt, Simon Daenen,

Leukemia

2011

78

Imatinib discontinuation in chronic phase myeloid leukaemia patients in sustained complete molecular response: A randomised trial of the Dutch–Belgian Cooperative Trial for Haemato-Oncology (HOVON)

Noortje Thielen, Bronno van der Holt, Jan J. Cornelissen,

European Journal of Cancer

2013

73

Page 1